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Abstract
 
Hematopoietic stem cells (HSCs) give rise to variety of hematopoietic cells via pluripotential
progenitors and lineage-committed progenitors and are responsible for blood production
throughout adult life. Amplification of HSCs or progenitors represents a potentially powerful
approach to the treatment of various blood disorders and to applying gene therapy by bone
marrow transplantation. Lnk is an adaptor protein regulating the production of B cells. Here
we show that Lnk is also expressed in hematopoietic progenitors in bone marrow, and that in
the absence of Lnk, the number and the hematopoietic ability of progenitors are significantly
increased. Augmented growth signals through c-Kit partly contributed to the enhanced he-
matopoiesis by 
 
lnk
 
 
 
/
 
 
 
 cells. Lnk was phosphorylated by and associated with c-Kit, and selec-
tively inhibited c-Kit–mediated proliferation by attenuating phosphorylation of Gab2 and acti-
vation of mitogen-activated protein kinase cascade. These observations indicate that Lnk plays
critical roles in the expansion and function of early hematopoietic progenitors, and provide
useful clues for the amplification of hematopoietic progenitor cells.
Key words: bone marrow transplantation • hematopoietic progenitors • c-Kit • stem cell 
factor • Gab2
 
Introduction
 
All blood cell lineages differentiate from hematopoietic
stem cells (HSCs)
 
*
 
 which self-renew to produce blood cells
throughout the entire lifetime of the organism (1). Recent
studies have demonstrated the potential of HSCs or pro-
genitor cells in bone marrow to give rise not only to blood
cells, but also to other cell types including hepatocytes, car-
diac myocytes, and epithelial cells of the liver, lung, gas-
trointestinal tract, and skin (2–4). Amplification of HSCs or
progenitors represents a potentially powerful approach to
the treatment of various blood disorders, to the regenera-
tion of damaged liver, heart, and lung tissues, and may also
allow the use of gene therapy by bone marrow transplanta-
tion. A modest net gain in HSC numbers has been reported
using serum-free cultures containing stem cell factor (SCF),
IL-11, and Flt-3 ligand (5). Thrombopoietin has also been
shown to promote HSC survival and induce the prolifera-
tion of HSCs in the presence of SCF (6, 7). However, cul-
ture conditions that allow the amplification of HSCs
while retaining their self-renewing abilities have not been
established, and the mechanism for the self-renewal of
HSCs remains poorly understood.
Lnk is an adaptor protein mainly expressed in lympho-
cytes (8–11). Lnk forms part of an adaptor protein family,
together with APS and Src homology (SH)2-B, whose
members share the presence of an NH
 
2
 
-terminal homolo-
gous domain, followed by pleckstrin homology and SH2
domains, and a COOH-terminal conserved tyrosine phos-
phorylation site (11–13). Lnk regulates B cell production
by negatively controlling the expansion of pro-B cells. We
have previously reported that mutant mice lacking the 
 
lnk
 
gene showed enhanced B cell production due to the hy-
persensitivity of B cell precursors to SCF, a ligand for c-Kit
(11). The absence of Lnk confers upon immature bone
marrow cells an enhanced ability to support B lymphopoie-
sis in adoptively transferred host animals, even in a com-
petitive environment such as nonirradiated recombination
activating gene (RAG)-2
 
 
 
/
 
 
 
 host (11).
The receptor tyrosine kinase c-Kit is a member of a sub-
family that includes the platelet-derived growth factor
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(PDGF), CSF-1, and Flt3/Flk-2 receptors (14, 15). As with
other receptor tyrosine kinases, stimulation of c-Kit by
SCF binding leads to dimerization, transphosphorylation,
and the recruitment and tyrosine phosphorylation of vari-
ous cellular proteins, including phosphatidylinositol 3-kinase
and Akt that rescue cells from apoptosis, and Gab2 that
leads to the activation of mitogen-activated protein kinase
(MAPK) pathways (16, 17). Through SCF binding, c-Kit
is a key controlling receptor in a number of cell types in-
cluding HSCs and hematopoietic progenitors, mast cells,
melanocytes, and germ cells. The growth and survival of
the stem cells for these cell types are severely affected by
mutations in the gene loci for c-Kit (
 
Kit
 
W
 
) or SCF (
 
sl
 
) (15).
In this study, we show that Lnk is also expressed in he-
matopoietic progenitors, and that in the absence of Lnk,
the number and the hematopoietic ability of progenitors
in bone marrow are significantly enhanced. Augmented
growth signals through c-Kit partly contribute to the en-
hanced hematopoiesis by 
 
lnk
 
 
 
/
 
 
 
 cells. Lnk is phosphory-
lated by and associates with c-Kit. Lnk selectively inhibits
c-Kit–mediated proliferation by inhibiting tyrosine phos-
phorylation of Gab2 and activation of the MAPK cascade.
These observations indicate that Lnk plays critical roles in
the expansion and function of early hematopoietic progen-
itors, and provide useful clues in the understanding of the
generation and proliferation of hematopoietic progenitor
cells.
 
Materials and Methods
 
Mice. lnk
 
 
 
/
 
 
 
 mice used in this study were backcrossed with
C57BL/6 (B6-Ly5.2) 
 
 
 
10 times. 
 
Kit
 
W/
 
 
 
 or 
 
Kit
 
Wv/
 
 
 
 mice were
purchased from The Jackson Laboratory. Mice congenic for the
Ly5 locus (B6-Ly5.1) were bred and maintained at the animal fa-
cility of the Institute of Medical Science, University of Tokyo,
Tokyo, Japan. All mice were housed and bled in specific patho-
gen-free conditions.
 
Flow Cytometry and RT-PCR.
 
Single cell suspensions were
prepared, and cells stained using predetermined optimal con-
centrations of the respective antibodies. The stained cells were
then analyzed on a FACScan™ or FACScalibur™ instrument
(Becton Dickinson). The following mAbs were used: FITC-
conjugated anti–Sca-1 (E13–161.7); PE-conjugated anti–c-Kit
(2B8); biotin-conjugated anti–TER-119; biotin-anti-Gr-1 (RB6–
8C5); PE- or biotin-anti-CD3
 
 
 
 (145–2C11); FITC-anti-CD8
(53–6.7); PE-anti-CD4 (RM4–5); PE–anti-CD43 (S7) (all pur-
chased from BD PharMingen); FITC- or biotin-anti-Mac-1
(M1/70); FITC-, PE-, or biotin-anti-B220 (RA3–6B2) (from
Caltag); and biotin-anti-Ly5.2 (a gift of K. Ikuta, Kyoto Uni-
versity, Japan). PE-conjugated streptoavidin (Ancell), or Tri-
Color-conjugated streptoavidin (Caltag) were used for biotin-
coupled antibody staining. Bone marrow cells were depleted of
lineage-committed cells using a MACS
 
®
 
 system (Miltenyi Bio-
tec) after incubation with a cocktail of biotin-conjugated anti-
bodies against various lineage markers (Lins) (B220, CD3, Gr-1,
Mac-1, and TER-119) and streptavidin-coupled microbeads.
Resulting Lin
 
 
 
 cells were stained with PE-anti-c-Kit, and
c-Kit
 
 
 
 or c-Kit
 
 
 
 cells sorted using a FACSVantage™ (Becton
Dickinson). Poly(A)
 
 
 
 RNA was isolated from purified cells us-
ing a Micro-Fast Track kit (Invitrogen), and first strand cDNA
templates synthesized by Superscript II reverse transcriptase
(GIBCO BRL) using random primers (TaKaRa, Kyoto, Japan).
Serial dilutions of cDNA templates were subjected to PCR am-
plification by using primer-sets encompassing several introns for
Lnk (FWD primer: 5
 
 
 
-ATGCCTGACAACCTCTACAC,
REV primer: 5
 
 
 
-ATTCACACGTCTGCCTCTCT) or 
 
 
 
-actin
(FWD primer: 5
 
 
 
-ACACTGTGCCCATCTACGAG, REV
primer: 5
 
 
 
-CTAGAAGCACTTGCGGTGCA). Cycling pa-
rameters were 1 min at 94
 
 
 
C, 2 min at 64
 
 
 
C and 3 min at 72
 
 
 
C
for 34 cycles to detect 
 
lnk
 
 mRNA, or 27 cycles for 
 
 
 
-actin.
PCR products were separated through 1.0% agarose gels and
stained with ethidium bromide.
 
Colony-forming Unit in Spleen Assay.
 
Nucleated bone mar-
row cells (10
 
5
 
) prepared from 
 
lnk
 
 
 
/
 
 
 
 or 
 
lnk
 
 
 
/
 
 
 
 mice were in-
jected into lethally irradiated (9.5 Gy) female wild-type mice.
The recipient mice were killed 12 d after the injection, and their
spleens were removed and fixed in Bouin’s solution for macro-
scopic examination to count colonies.
 
Competitive Repopulation Assay.
 
Bone marrow cells obtained
from 
 
lnk
 
 
 
/
 
 
 
 or 
 
lnk
 
 
 
/
 
 
 
 mice (Ly5.2) were depleted of lineage-
committed cells using a MACS
 
®
 
 system as described above. Re-
sulting Lin
 
 
 
 cells (7.0 
 
 
 
 10
 
4
 
) were intravenously injected into le-
thally irradiated (9.5 Gy) recipient mice together with 3.5 
 
 
 
 10
 
5
 
competitor Lin
 
  
 
cells obtained from B6-Ly5.1 mice. For assays
using 
 
lnk
 
 
 
/
 
 
 
Kit
 
 
 
/
 
 
 
 or 
 
lnk
 
 
 
/
 
 
 
Kit
 
W/
 
 
 
 mice, 1.5 
 
 
 
 10
 
5
 
 or 7.5 
 
 
 
 10
 
4
 
bone marrow cells were injected into lethally irradiated recipient
mice together with 1.5 
 
 
 
 10
 
6
 
 competitor bone marrow cells ob-
tained from B6-Ly5.1 mice. Bone marrow cells, splenocytes, and
thymocytes of chimeric animals were isolated and analyzed 10–12
wk after transfer.
 
Plasmid Construction and Transfection.
 
Full-length 
 
lnk
 
 cDNA
(11) was subcloned into the BamHI site of pcDNA3 (Strat-
agene), an eukaryotic expression vector driven by the cytomega-
lovirus enhancer and promoter, resulting in pcDNA3-Lnk. Sub-
stitutional mutations were introduced into the 
 
lnk
 
 cDNA
sequence encoding the COOH-terminal tyrosine residue (Y536)
by PCR-based site-directed mutagenesis. The introduced muta-
tion was confirmed by DNA sequencing. The resulting mutated
cDNA was subcloned into pcDNA3 (pcDNA3-Y536F). A
mouse mast cell line, MC9 was grown in RPMI 1640 medium
supplemented with 5% FCS, 50 
 
 
 
M 2-ME, 100 U/ml penicillin,
and 100 
 
 
 
g/ml streptomycin and 10 U/ml mIL-3. MC9 cells
were transfected by electroporation with pcDNA3-Lnk or
pcDNA3-Y536F linearized with 
 
Ssp
 
I. 2 d after transfection, cells
were seeded into 96-well plates (10
 
4
 
 cells per well) and selected
in medium containing 0.8 mg/ml G418. Transfectants resistant
to G418 were expanded and screened for expression of Lnk pro-
tein by immunoblotting.
 
Proliferation Assay and Immunoblotting.
 
Transfectants (10
 
4
 
) were
cultivated in 200 
 
 
 
l of medium in 96-well plates. Cells were
stimulated with various concentrations of SCF or IL-3. Cells
were pulse-labeled with [
 
3
 
H]thymidine (0.2 
 
 
 
Ci per well) during
the last 16-h of the 72-h culture period, and incorporated
[
 
3
 
H]thymidine measured using a MATRIX 96 Direct Beta
Counter (Packard Instrument Co.). Transfectants were washed in
Hanks’ Balanced Salt solution three times and starved in RPMI
1640 medium containing 2% FCS, 50 
 
 
 
M 2-ME for 4 h. Cells
were then collected and stimulated with 1 
 
 
 
g/ml SCF (Pepro-
Tech) for the indicated times. After stimulation, cells were col-
lected and lysed on ice in lysis buffer (150 mM NaCl, 50 mM
Tris HCl, pH 7.5, 1% NP-40, 10 mM NaF, 1 mM Na
 
3
 
VO
 
4
 
, 2
mM phenylmethylsulfonyl fluoride, 10 
 
 
 
g/ml leupeptin, 10 
 
 
 
g/
ml aprotinin) and the lysates clarified by centrifugation. Whole 
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cell lysates or proteins immunoprecipitated using anti-Lnk (11) or
anti-Gab2 (Upstate Biotechnology) were resolved by SDS/
8%PAGE under reducing conditions, and transferred onto nitro-
cellulose membranes (Schleicher and Schull). After blocking with
5% skim milk/PBS, blots were probed with antiphosphotyrosine
mAb (4G10; Upstate Biotechnology), anti–phospho-Akt, or
anti–phospho-Erk1/2 (New England BioLabs), anti–c-Kit (Santa
Cruz Biotechnology, Inc.) or anti-Lnk antibodies, and incubated
with horseradish peroxidase-conjugated secondary antibodies.
Filters were washed in 0.05% Tween 20, Tris-buffered saline, pH
7.5, and developed by enhanced chemiluminescence (NEN Life
Science Products).
 
Results
 
Increased Number and Enhanced Ability of Hematopoietic Pro-
genitors in lnk
 
 
 
/
 
 
 
 Mice.
 
The hyperresponsivity of 
 
lnk
 
 
 
/
 
 
 
precursor B cells to SCF and the enhanced ability to sup-
port B lymphopoiesis in nonirradiated RAG-2
 
 
 
/
 
 
 
 host
animals (11) prompted us to investigate the function of
Lnk in more immature hematopoietic progenitor cells.
We first examined whether immature progenitors not yet
committed to the B cell lineage expressed 
 
lnk
 
 mRNA.
Bone marrow cells that already expressed Lins were de-
pleted and resulting Lin-negative (Lin
 
 
 
) immature cells
were further purified by the expression of c-Kit. RT-
PCR results demonstrated that 
 
lnk
 
 mRNA was expressed
in Lin
 
 
 
 bone marrow cells. Among these Lin
 
  
 
cells, more
 
lnk
 
 transcripts were observed in immature c-Kit
 
 
 
 cells
than in c-Kit
 
 
 
 cells (Fig. 1 A). Then we compared the dis-
tribution of cells expressing c-Kit and Sca-1 within the
Lin
 
 
 
 cell population obtained from 
 
lnk
 
 
 
/
 
 
 
 or 
 
lnk
 
 
 
/
 
 
 
 mice.
The Lin
 
 
 
c-Kit
 
 
 
Sca-1
 
 
 
 fraction, within which HSCs are
found (18), was significantly expanded in 
 
lnk
 
 
 
/
 
 
 
 mice
compared with 
 
lnk
 
 
 
/
 
 
 
 mice (Fig. 1 B, Table III). Pluripo-
tential hematopoietic progenitors give rise to CFU in
spleen (CFU-S) after 12 d when transplanted into lethally
irradiated host. CFU-S d12 in 
 
lnk
 
 
 
/
 
 
 
 bone marrow was
significantly increased compared with wild-type (Table I,
Fig. 1 C). In addition, CFU-S d12 colonies derived from
 
lnk
 
 
 
/  cells were larger in size than those derived from
lnk /  cells, suggesting the enhanced proliferating ability
of lnk /  hematopoietic progenitors.
The ability of lnk /  progenitors to produce various he-
matopoietic cell types was examined by competitive repop-
ulation assay. To avoid the contribution of increased B cell
precursor populations in lnk /  bone marrow to recipient
B cell compartments, Ly5.2 Lin  cells were purified from
lnk /  or lnk /  mice and transferred into irradiated hosts
together with a fivefold excess of Ly5.1  normal Lin  cells
(Fig. 2 A). Reflecting the ratio of testee to competitor cells,
only small part of B220loCD43  B-lineage cells in bone
marrow and B220  splenocytes were Ly5.2  in recipient
mice repopulated using lnk /  Ly5.2  progenitors (Fig. 2
B). In contrast, when lnk /  Ly5.2  progenitors were used,
almost all of the B lineage cells were Ly5.2  despite the
original transfer of five times fewer lnk /  progenitors than
normal Ly5.1  competitor cells (Fig. 2 B). This also dem-
onstrates the enhanced ability of lnk /  progenitors to pro-
duce B lineage cells compared with normal progenitors.
Unexpectedly, results of the competitive repopulation assay
showed that the lnk /  progenitors produced not only B
lineage cells but also myeloid cells and T cells more effi-
ciently than normal progenitors (Fig. 2 B, Table II). Most
of the B220 CD43  myeloid cells in bone marrow and
Mac-1  splenocytes in mice that received lnk /  progeni-
tors were Ly5.2 . In addition, most CD4 CD8  thy-
mocytes and CD3  splenocytes were generated from lnk / 
Figure 1. Increased hematopoietic progenitors in lnk /  mice. (A) Ex-
pression of lnk transcripts in hematopoietic progenitor cells of normal mice.
Lin  bone marrow cells were purified and separated according to c-Kit ex-
pression. Serial dilutions (threefold) of cDNA templates were prepared and
subjected to RT-PCR analysis using primer sets designed to amplify lnk
(top) or  -actin (bottom) cDNA fragments. (B) The cell fraction contain-
ing HSCs (Lin Sca-1 c-Kit ) was increased in the bone marrow of lnk / 
mice. Sca-1 and c-Kit expression on Lin  bone marrow cells prepared
from lnk /  or lnk /  mice was analyzed by flow cytometry. Representa-
tive dual parameter plots are shown. (C) Increased hematopoietic progeni-
tors (CFU-S d12) caused by the lnk-deficiency. Bone marrow cells (105)
were transplanted into lethally irradiated recipient mice. The spleens were
removed after 12 d and fixed in Bouin’s solution to visualize the colonies.
Table I. Increased CFU-S d12 in the Bone Marrow of the
lnk /  Mice
Genotype CFU-S d12 (per 105 cells)
lnk /  11.5   2.4
lnk /  20.8   3.3a
Bone marrow cells (105) were administered intravenously to lethally
irradiated recipient mice. The spleens were removed and fixed 12 d after
injection, and the number of colones was counted. The values are
mean   SD for quadruplicates. 
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progenitors even in the presence of five times more normal
progenitors. Most of the IL-2R  CD3  NKT cells in the
spleen and thymus were also derived from lnk /  progeni-
tors (data not shown). These results indicate that the abil-
ity of hematopoietic progenitors to generate various lin-
eages of hematopoietic cells is greatly enhanced by the
absence of Lnk.
c-Kit Signaling Is a Major Target Affected by lnk Deficiency.
We have previously demonstrated that B cell overpro-
duction observed in lnk /  mice was due, at least in part to
SCF hypersensitivity of the precursors, reflecting enhanced
c-Kit signaling in the absence of Lnk (11). To confirm our
observations in vivo, we bred lnk /  mice to KitW/  mutant
mice. The KitW mutation consists of a deletion in the c-Kit
protooncogene that results in reduced cell surface expression
of c-Kit protein in KitW/  heterozygote mice (19). KitW/Wv
mice are commonly used as viable mutant mice carrying
nonfunctional c-Kit. However, the fraction of B lineage
cells in the bone marrow of these mice varied from animal
to animal, presumably due to malnutrition accompanied
with severe anemia. Therefore, we compared Kit /  with
KitW/  mutant mice in a lnk /  background. KitW/  mice
(lnk / KitW/ ) showed no abnormalities in B cell develop-
ment compared with normal (lnk / Kit / ) mice (Table
III). Total bone marrow preparations from lnk / Kit / 
mice contained higher cell numbers than from normal mice,
with both B220loIgM  and B220loIgM  fractions signifi-
cantly increased. Reduction of c-Kit expression by the in-
troduction of the KitW mutation on a lnk /  background
partially but significantly normalized B cell overproduction
in  lnk / KitW/  mice (Table III). This confirms that the
main reason for B cell overproduction in lnk /  mice is en-
hanced signaling through the c-Kit tyrosine kinase receptor.
The fraction of Lin Sca-1 c-Kit  progenitors in lnk / 
KitW/  bone marrow was then examined. Expression levels
of c-Kit were reduced in lnk / KitW/  mice compared
with lnk / Kit /  mice (Fig. 3 A). Importantly, the in-
creased Lin Sca-1 c-Kit  fraction in lnk / Kit /  mice
was partly but significantly reduced in lnk / KitW/  mice
(Fig. 3 A, Table III). This suggests that the increase in
numbers of hematopoietic progenitors in lnk /  mice also
results from enhanced c-Kit signaling. Despite the partial
normalization of B cell overproduction and increased
Lin Sca-1 c-Kit  progenitors, the competitive repopula-
tion assay demonstrated an enhanced ability of hematopoi-
etic progenitors from lnk / KitW/  mice comparable to
that from lnk / Kit /  mice. Both lnk / KitW/  and lnk / 
Kit /  progenitors (Ly5.2 ) generated most of the B and
myeloid lineage cells and thymocytes in the presence of 10-
fold more competitor cells (Ly5.1 ) (Fig. 3 B, Table IV).
Even in the presence of 20-fold more competitor cells,
lnk / KitW/  as well as lnk / Kit /  progenitors continued
to generate the majority of B, myeloid and T lineage cells
(Fig. 3 B, Table IV). These results strongly suggest that the
enhanced hematopoietic ability of lnk /  progenitors in-
volves as yet unidentified mechanism(s), in addition to the
enhanced c-Kit signaling that lead to the increase of
Lin ca-1 c-Kit  progenitors.
Mechanisms for the Selective Inhibition of c-Kit Signaling by
Lnk. The mechanism by which Lnk regulates signaling
through c-Kit was studied using the SCF-dependent mast
cell line MC9, which endogenously expresses low levels of
Lnk (Fig. 4 A). MC9 transfectants that expressed Lnk at
moderate (Lnk#1) or high (Lnk#2) levels were established
and responsiveness to SCF examined. APS, a member of
the Lnk adaptor family, is phosphorylated at a tyrosine resi-
due at the COOH-terminal end and forms a binding site
for c-Cbl (13), which is involved in the degradation of var-
Figure 2. Enhanced repopulating ability of lnk /  progenitors demon-
strated by a competitive repopulation assay. (A) Lin  bone marrow cells
prepared for repopulating assay. Bone marrow cells obtained from lnk / ,
lnk /  mice, or B6-Ly5.1 (competitor) mice were depleted of lineage-
committed cells using a MACS® system as described in Materials and
Methods. Expression of Lin markers (B220, CD3, Gr-1, Mac-1, and
TER-119) on cells before depletion (dotted lines) or after depletion (solid
lines) was shown. (B) Lin  cells obtained from lnk /  or lnk /  mice
(Ly5.2) were transferred into lethally irradiated (9.5 Gy) recipient
mice together with a fivefold excess of Lin  cells prepared from nor-
mal B6-Ly5.1 mice. Ly5.2 expression on B220loCD43  B lineage cells
in bone marrow, B220 CD43  myeloid cells in bone marrow,
CD4 CD8  thymocytes, B220  splenic B cells, Mac-1  splenocytes, and
CD3  splenic T cells were analyzed 10–12 wk after transfer. Upper pro-
files show results obtained from animals transferred with lnk /  cells, and
lower profiles show results obtained from animals transferred with lnk / 
cells. Representative results of three independent experiments are shown.155 Takaki et al.
tion is not affected in the presence of excess amounts of
Lnk. Interestingly, SCF-induced proliferative responses
were impaired in a dose–response manner by Lnk expres-
sion (Fig. 4 C). However, IL-3–induced proliferation re-
mained intact. Y536F also showed impaired proliferation
upon stimulation by SCF but not by IL-3. Apoptosis of
MC9 cells induced by the depletion of SCF and IL-3 was
not affected by overexpression of Lnk (data not shown).
Therefore, Lnk selectively inhibits growth signaling medi-
ated through c-Kit and the putative c-Cbl binding site of
Lnk is not required for the negative regulatory effect on
c-Kit.
We next analyzed the tyrosine phosphorylation of cellular
proteins. SCF stimulation rapidly induced tyrosine phos-
phorylation of various cellular proteins, including c-Kit.
Table II. Repopulating Ability of Hematopoietic Progenitors in Irradiated Hosts Is Enhanced by the Absence of Lnk
Percent chimerism (Ly5.2  cells, %)
Experiment Tested donor
Bone marrow
B220loCD43 
Bone marrow
B220 CD43 
Thymus
CD4 CD8 
Exp. 1 Ly5.1 alone 2.3 7.4 0.1
lnk /  10.9 28.9 0.1
lnk    87.1 48.9 99.8
lnk    85.1 78.1 87.5
Exp. 2 lnk    16.6 23.9 17.2
lnk    18.0 16.9 16.1
lnk    97.5 93.9 99.2
lnk    97.6 95.8 99.4
Exp. 3 Ly5.1 alone 5.4 9.9 2.2
lnk    33.3 42.3 30.4
lnk    94.8 96.3 99.7
lnk    95.3 95.2 98.2
Lin  bone marrow cells obtained from lnk+/+ or lnk /  mice (Ly 5.2) were transferred into lethally irradiated (9.5 Gy) recipient mice together with
a fivefold excess of Lin  cells prepared from normal B6-Ly5.1 mice. Bone marrow cells and thymocytes were isolated 10–12 wk after transfer, and
percentage of Ly5.2+ cells in the indicated cell fractions were determined.
ious proteins (20). The phosphorylation of the c-Cbl bind-
ing site is required for the negative regulatory functions of
APS in cytokine receptor signaling, such as through
PDGF-R and erythropoietin-R (21, 22). Therefore, we
also generated transfectants that expressed a mutant Lnk
(Y536F) that carried a substitution at the COOH-terminal
tyrosine residue expected to be phosphorylated by analogy
with APS. Lnk#2 and Y536F expressed c-Kit at amounts
comparable with control transfectants (Neo), and c-Kit was
similarly downregulated in all three transfectants upon
stimulation with SCF (Fig. 4 B). Even when the transfec-
tants were stimulated with low amounts of SCF, no dif-
ferences between transfectants were detected (data not
shown). This indicates that early signals are efficiently
transmitted, and that the c-Kit degradation or internaliza-
Table III. B Cell Overproduction and Increased in Lin Sca-1 c-Kit  Hematopoietic Progenitors in lnk /  Mice Is Partly Normalized by 
Reducing Expression of c-Kit
Genotype Cell number B220loIgM  B220loIgM  Lin Sca-1 c-Kit 
(107 cells/femur) (%) (%) (%) (% in Lin  cells)
lnk+/+Kit+/+ 1.65   0.16 19.5   5.1 8.9   3.6 (n   12) 0.45   0.07 16.2   2.2 (n   5)
lnk+/+KitW/+ 1.71   0.19 18.2   4.6 8.0   3.1 (n   10) 0.38   0.06 14.9   1.7 (n   4)
lnk / Kit+/+  2.03    0.37a 3.6   4.8a 14.1   2.1a (n   11) 0.70    0.06a 26.1   2.1a (n   5)
lnk / KitW/+ 1.91   0.28 28.9   3.9b 11.8   1.7b (n   8) 0.56   0.13 21.3   1.4b (n   5)
Bone marrow cells obtained from 8–10-wk-old mice were analyzed, and mean cell number ( SD), mean percentage ( SD) of the indicated cell
fractions and the number of mice analyzed are shown.
aP   0.05 compared to lnk+/+Kit+/+.
bP   0.05 compared to lnk / Kit+/+.156 Enhanced Hematopoiesis by the Lnk-deficient Hematopoietic Progenitor Cells
Figure 3. Increased number but not enhanced ability of lnk /  he-
matopoietic progenitors is partly normalized by reducing expression of
c-Kit. (A) Expression of Sca-1 and c-Kit on Lin  bone marrow cells of
lnk / Kit /  or lnk / KitW/  mice. Shown are representative dual pa-
rameter plots analyzed by flow cytometry. (B) Comparable repopulating
ability of progenitors obtained from lnk / Kit /  or lnk / KitW/  mice.
Bone marrow cells obtained from lnk / Kit /  or lnk / KitW/  mice
(Ly5.2) were transferred into lethally irradiated (9.5 Gy) recipient
mice together with 10 times (top) or 20 times (bottom) more competitor
cells prepared from normal B6-Ly5.1 mice. Ly5.2 expression on B220lo
CD43  B lineage cells in bone marrow, B220-CD43  myeloid cells in
bone marrow, and CD4 CD8  thymocytes of chimeric animals were an-
alyzed 10–12 wk after transfer. Upper profiles show results obtained from
animals transferred with lnk / Kit /  cells, and lower profiles show re-
sults obtained from animals transferred with lnk / KitW/  cells. Thin lines
in top panels show profiles of mice transferred with Ly5.1 competitor
cells alone. Representative results of two independent experiments are
shown.
Table IV. Comparable Repopulating Ability of HSCs Obtained from lnk / Kit /  or lnk / KitW/  Mice
Percent chimerism (Ly5.21 cells, %)
Experiment Tested donor
Testee:
Competitor
Bone marrow
B220loCD43 
Bone marrow
B220loCD43 
Thymus
CD4 CD8 
Exp. 1 Ly5.1 alone 4.7 5.1 0.3
lnk / Kit+/+ 1:10 98.1 76.6 94.8
lnk / KitW/+ 1:10 98.4 73.1 77.5
lnk / Kit+/+ 1:20 98.5 71.1 96.1
lnk / KitW/+ 1:20 94.4 64.4 24.6
Exp. 2 Ly5.1 alone 4.4 3.1 0.1
lnk / Kit+/+ 1:10 81.2 65.8 81.2
lnk / KitW/+ 1:10 87.6 77.1 76.9
lnk / Kit+/+ 1:20 86.1 67.3 97.0
lnk / KitW/+ 1:20 87.2 74.5 86.8
Bone marrow cells obtained from lnk /  Kit+/+ or lnk / KitW/+ mice (Ly5.2) were transferred into lethally irradiated (9.5 Gy) recipient mice together
with 10-fold or 20-fold excess of competitor bone marrow cells prepared from normal B6-Ly5.1 mice. Bone marrow cells and thymocytes were
isolated 10–12 wk after transfer, and percentage of Ly5.2+ cells in the indicated cell fractions was determined.157 Takaki et al.
The pattern of protein tyrosine phosphorylation was com-
parable between the three transfectants except for the atten-
uation of phosphorylation of a 90–100-kD protein in
Lnk#2 and Y536F cells (Fig. 4 D). c-kit itself was efficiently
phosphorylated, and we observed neither attenuated nor
augmented c-Kit phosphorylation. Akt was also similarly
phosphorylated among the three transfectants (Fig. 4 D). In-
terestingly, MAPK activation as detected by its phosphory-
lation was perturbed in Lnk#2 and Y536F, correlating with
the attenuated phosphorylation of the 90–100-kD protein.
Immunoprecipitation experiments demonstrated that Lnk
was phosphorylated by and associated with c-Kit. This asso-
ciation was dependent on phosphorylation of c-Kit, but not
of Lnk, as the mutant Lnk Y536F was no longer phosphor-
ylated upon SCF stimulation but still efficiently bound c-Kit.
Finally, the 90–100 kD phosphoprotein was identified as
Gab2, which is thought to be a substrate of c-Kit (17). Anti-
Gab2 reacted with and immunoprecipitated the 90–100 kD
phosphoprotein (Fig. 4 D). These results demonstrate that
Lnk is a substrate of c-Kit, specifically interacting with
phosphorylated c-Kit, and that Lnk negatively regulates
c-Kit-mediated signaling for cell growth, at least in part, by
attenuating Gab2 phosphorylation and the subsequent acti-
vation of the MAPK pathway.
Discussion
We demonstrated that hematopoietic progenitors were
increased in the bone marrow of lnk /  mice as a conse-
quence of enhanced c-Kit signaling, and that lnk /  he-
matopoietic progenitors exhibited a greatly increased capac-
ity to repopulate and produce various blood cell lineages
after transplantation into lethally irradiated host animals.
While it is likely that the increased progenitor fraction
partly accounts for the enhanced hematopoiesis by lnk / 
progenitors, the enhanced hematopoiesis by lnk / KitW/ 
progenitors was comparable to that by lnk / Kit /  pro-
genitors in competitive repopulation assays. This suggests
the existence of Lnk-dependent but c-Kit–independent sig-
naling pathways that lead to the augmented ability of he-
matopoietic progenitors to repopulate host bone marrow
and undergo hematopoiesis. Flt3/Flk-2 may be involved in
such a pathway as it has been shown to support proliferation
and differentiation of hematopoietic progenitor cells, while
disruption of the Flt3/Flk-2 perturbed the production of
various blood cell lineages (23). However, injection of anti-
Flt3/Flk-2 antibodies into lnk /  mice failed to normalize
the B cell overproduction in lnk /  mice (unpublished
data), indicating that Flt3/Flk-2 signaling is not likely to be
a target affected by the lnk-deficiency. Alternatively, the fact
that the increased reconstituting activity of lnk /  progeni-
tors was not affected by the reduction of c-Kit expression
would indicate difference in the threshold of c-Kit–depen-
dent signals in early hematopoietic progenitors or HSCs,
late-stage progenitors and B cell precursors. Since c-Kit is
not absent but only reduced in KitW/  mice, c-Kit signaling
with a relatively low threshold in early progenitors or HSCs
Figure 4. Lnk specifically inhibits c-Kit–mediated growth signaling in
MC9 cells responsive to SCF or IL-3. (A) MC9 cells were transfected
with expression plasmid without insert (Neo), plasmid encoding Lnk
(Lnk#1, Lnk#2), or mutant Lnk (Y536F) that lacks the COOH-terminal
tyrosine phosphorylation site. Lnk protein expression levels were analyzed
by immunoblot. (B) Downregulation of c-Kit induced by SCF. Expres-
sion levels of c-Kit on unstimulated MC9 transfectants (broken lines) or
cells stimulated with 100 ng/ml SCF for 30 min (solid lines) were ana-
lyzed by flow cytometry. Representative results of multiple experiments
are shown. (C) Proliferative responses of parental MC9 ( ), Neo ( ),
Lnk#1 ( ), Lnk#2 ( ), and Y536F ( ) upon stimulation with various
concentrations of SCF (top) or IL-3 (bottom). Values shown are mean  
SD of triplicate determinations. Representative results of three indepen-
dent experiments are shown. (D) Phosphorylation of cellular proteins in-
duced by SCF stimulation of MC9 transfectants. Transfectants were
starved for 4 h and stimulated with 1  g/ml of SCF for the indicated
times. Whole cell lysates (top), anti-Lnk immunoprecipitants (middle),
and anti-Gab2 immunoprecipitants (bottom) were separated through
SDS/PAGE gels and transferred onto nitrocellulose membranes. Result-
ant membranes were probed with the indicated antibodies and visualized
by ECL. Representative results of multiple experiments are shown.158 Enhanced Hematopoiesis by the Lnk-deficient Hematopoietic Progenitor Cells
might fully function in the condition where c-Kit–depen-
dent growth signaling in the majority of Lin c-Kit Sca-1 
progenitors and B cell precursors were affected.
We found that Lnk is also expressed in hematopoietic
progenitors and that the ability to generate various lineages
of blood cells was significantly enhanced in irradiated host
animals in the absence of Lnk. In lnk /  mice, however,
the B lineage is affected to a greater degree while other
lineages of cells are kept intact. The high expression of
Lnk in B lineage cells (9) presumably accounts for the se-
lective accumulation of B cells in lnk /  mice despite the
importance of c-Kit in directing the development of a
wide-range of blood cells. As Lnk expression is maintained
at a high level in the B cell lineage in normal mice, B cell
lineage is severely affected in the absence of Lnk. Al-
though other lineage of lnk /  cells may also have some
growth advantage compared with corresponding wild-
type cells, the advantage is likely to be masked by a mas-
sively enhanced growth ability of B lineage cells in lnk / 
bone marrow.
Biochemical analysis using c-Kit  MC9 cells demon-
strated that Lnk was tyrosine-phosphorylated by c-Kit and
interacted with phosphorylated c-Kit. Lnk specifically in-
hibited c-Kit–mediated signaling for cell growth, at least in
part, by attenuating Gab2 phosphorylation and the subse-
quent activation of MAPK pathway. Although the residue
of Y536 of Lnk was the main target of c-Kit, tyrosine phos-
phorylation of Y536 was not required for the negative reg-
ulatory effect of Lnk on c-Kit. Moreover, SCF-induced
downregulation of c-Kit was not affected by Lnk overex-
pression. These are in contrast to APS that inhibits Janus ki-
nase (JAK)2 or PDGF-R–mediated signaling in combina-
tion with c-Cbl. Phosphorylation of the COOH-terminal
tyrosine is essential for c-Cbl binding and subsequent inhib-
itory effects of APS (21, 22). The inhibitory function of Lnk
on c-Kit is also in contrast to the positive regulatory roles of
SH2-B and APS in signaling via receptors for various cyto-
kines and growth factors (24–26), while both SH2-B and
APS share significant similarities in structure with Lnk.
Phosphorylation of cellular proteins induced by c-Kit
stimulation was hardly detectable in primary progenitor
cells prepared freshly from normal or lnk /  bone marrow
cells. Even if we used primary pro-B cells obtained by a
long-term bone marrow culture, c-Kit–dependent phos-
phorylation was hardly detectable. Given the ubiquitous
expression of MAPK pathway components and Gab2 (17,
27), however, the observation obtained using mast cell
lines overexpressing Lnk should reflect the function of Lnk
in hematopoietic progenitors exposed to low concentration
of SCF in the bone marrow microenvironment. The trans-
genic mice overexpressing Lnk in B cell precursors resulted
in the reduction of B lineage cells (unpublished data), pre-
senting a good contrast to the phenotype of lnk /  mice
and a reasonable synonym with the inefficient SCF-depen-
dent growth of MC9 cells overexpressing Lnk. Recently, it
has been reported that Gab2 /  mice are viable and show
normal steady-state hematopoiesis except reduced mast
cells in skins and peritoneal cavity (28). Gab2 is expressed
widely like its related protein Gab1 (17, 27), and both
Gab1 and Gab2 are involved in MAPK activation in re-
sponse to several growth factors and cytokines (17). Bone
marrow–derived mast cells, however, express only Gab2
but not Gab1 (28). Although Lnk overexpression resulted
in attenuated phosphorylation of Gab2 in mast cell line
MC9, Lnk might also act on and regulate Gab1 in other
lineages of cells. Whether Lnk regulates Gab1 as well as
Gab2 and whether Gab1 and Gab2 function redundantly in
hematopoietic progenitors remain to be elucidated.
The expression of c-Kit has been one of best markers
for HSCs commonly used in various purification protocols
to enrich HSCs (18, 29–32). The definitive hematopoiesis
is severely perturbed by mutations in the gene loci for
c-Kit (KitW) or SCF (sl) (15). In addition, administration of
anti–c-Kit antibodies abrogates development of hemato-
poietic cells (29, 30). These indicate the importance of
c-Kit expressed on HSCs. Recent report, however, has
demonstrated the existence of c-Kit  HSC fraction (33).
Although c-Kit  HSCs that are dormant/quiescent popu-
lation do not radioprotect or form CFU-S, they show de-
layed or slow reconstitution kinetics when cotransplanted
with radioprotective bone marrow cells. c-Kit  HSCs can
give rise to c-Kit  HSCs not in primary recipients but in
secondary recipients when transplanted repeatedly into ir-
radiated hosts (33). One of possible dysregulations caused
by the lnk-deficiency resulting in the enhanced hemato-
poiesis might be a rapid and augmented transition from
c-Kit  HSCs into c-Kit  HSCs in irradiated hosts that is
independent on c-Kit signaling.
Defined characterization of lnk /  HSCs by the evalua-
tion of the hematopoietic ability of single HSC and the re-
population to various tissues other than blood cells will be
of great interest. HSCs transferred into host animals need to
migrate into bone marrow, find a marrow niche best suited
for their self-renewal, then proliferate and differentiate.
Studying the effect of the lnk-deficiency on HSCs and clar-
ifying the processes affected by the lnk-deficiency would
provide useful information to reveal HSCs function in
vivo. In addition, identification of Lnk-dependent signaling
pathways and target genes that exhibit altered expression
levels in the absence of Lnk would provide useful clues in
the understanding of the self-renewal abilities of HSCs or
the expansion of progenitor cells. Inhibiting Lnk function
by a mutant form of Lnk, inhibition of Lnk-dependent sig-
naling pathways, or forced expression of Lnk-target genes
may eventually allow us to control the expansion and gen-
eration of hematopoietic progenitor cells from HSCs.
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